128 related articles for article (PubMed ID: 29721934)
1. Optimizing Non-viral Gene Therapy Vectors for Delivery to Photoreceptors and Retinal Pigment Epithelial Cells.
Zulliger R; Watson JN; Al-Ubaidi MR; Padegimas L; Sesenoglu-Laird O; Cooper MJ; Naash MI
Adv Exp Med Biol; 2018; 1074():109-115. PubMed ID: 29721934
[TBL] [Abstract][Full Text] [Related]
2. Suprachoroidal Delivery of Viral and Nonviral Gene Therapy for Retinal Diseases.
Kansara V; Muya L; Wan CR; Ciulla TA
J Ocul Pharmacol Ther; 2020; 36(6):384-392. PubMed ID: 32255727
[TBL] [Abstract][Full Text] [Related]
3. Synthetic Adeno-Associated Viral Vector Efficiently Targets Mouse and Nonhuman Primate Retina In Vivo.
Carvalho LS; Xiao R; Wassmer SJ; Langsdorf A; Zinn E; Pacouret S; Shah S; Comander JI; Kim LA; Lim L; Vandenberghe LH
Hum Gene Ther; 2018 Jul; 29(7):771-784. PubMed ID: 29325457
[TBL] [Abstract][Full Text] [Related]
4. The effects of PEGylation on LNP based mRNA delivery to the eye.
Ryals RC; Patel S; Acosta C; McKinney M; Pennesi ME; Sahay G
PLoS One; 2020; 15(10):e0241006. PubMed ID: 33119640
[TBL] [Abstract][Full Text] [Related]
5. Targeting photoreceptors via intravitreal delivery using novel, capsid-mutated AAV vectors.
Kay CN; Ryals RC; Aslanidi GV; Min SH; Ruan Q; Sun J; Dyka FM; Kasuga D; Ayala AE; Van Vliet K; Agbandje-McKenna M; Hauswirth WW; Boye SL; Boye SE
PLoS One; 2013; 8(4):e62097. PubMed ID: 23637972
[TBL] [Abstract][Full Text] [Related]
6. Optimized technique for subretinal injections in mice.
Mühlfriedel R; Michalakis S; Garcia Garrido M; Biel M; Seeliger MW
Methods Mol Biol; 2013; 935():343-9. PubMed ID: 23150380
[TBL] [Abstract][Full Text] [Related]
7. Differential targeting of feline photoreceptors by recombinant adeno-associated viral vectors: implications for preclinical gene therapy trials.
Minella AL; Mowat FM; Willett KL; Sledge D; Bartoe JT; Bennett J; Petersen-Jones SM
Gene Ther; 2014 Oct; 21(10):913-20. PubMed ID: 25056608
[TBL] [Abstract][Full Text] [Related]
8. Gene therapy following subretinal AAV5 vector delivery is not affected by a previous intravitreal AAV5 vector administration in the partner eye.
Li W; Kong F; Li X; Dai X; Liu X; Zheng Q; Wu R; Zhou X; Lü F; Chang B; Li Q; Hauswirth WW; Qu J; Pang JJ
Mol Vis; 2009; 15():267-75. PubMed ID: 19190735
[TBL] [Abstract][Full Text] [Related]
9. Novel AAV44.9-Based Vectors Display Exceptional Characteristics for Retinal Gene Therapy.
Boye SL; Choudhury S; Crosson S; Di Pasquale G; Afione S; Mellen R; Makal V; Calabro KR; Fajardo D; Peterson J; Zhang H; Leahy MT; Jennings CK; Chiorini JA; Boyd RF; Boye SE
Mol Ther; 2020 Jun; 28(6):1464-1478. PubMed ID: 32304666
[TBL] [Abstract][Full Text] [Related]
10. Changes in adeno-associated virus-mediated gene delivery in retinal degeneration.
Kolstad KD; Dalkara D; Guerin K; Visel M; Hoffmann N; Schaffer DV; Flannery JG
Hum Gene Ther; 2010 May; 21(5):571-8. PubMed ID: 20021232
[TBL] [Abstract][Full Text] [Related]
11. Improvement of Photoreceptor Targeting via Intravitreal Delivery in Mouse and Human Retina Using Combinatory rAAV2 Capsid Mutant Vectors.
Reid CA; Ertel KJ; Lipinski DM
Invest Ophthalmol Vis Sci; 2017 Dec; 58(14):6429-6439. PubMed ID: 29260200
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Photoreceptor Transduction Efficacy of Capsid-Modified Adeno-Associated Viral Vectors Following Intravitreal and Subretinal Delivery in Sheep.
Ross M; Obolensky A; Averbukh E; Ezra-Elia R; Yamin E; Honig H; Dvir H; Rosov A; Hauswirth WW; Gootwine E; Banin E; Ofri R
Hum Gene Ther; 2020 Jul; 31(13-14):719-729. PubMed ID: 32486858
[TBL] [Abstract][Full Text] [Related]
13. Adenovirus vectors targeting distinct cell types in the retina.
Sweigard JH; Cashman SM; Kumar-Singh R
Invest Ophthalmol Vis Sci; 2010 Apr; 51(4):2219-28. PubMed ID: 19892875
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of rAAV2-mediated transgene expression in retina cells in vitro and in vivo by coadministration of low-dose chemotherapeutic drugs.
Zhang S; Wu J; Wu X; Xu P; Tian Y; Yi M; Liu X; Dong X; Wolf F; Li C; Huang Q
Invest Ophthalmol Vis Sci; 2012 May; 53(6):2675-84. PubMed ID: 22427581
[TBL] [Abstract][Full Text] [Related]
15. Defining Phenotype, Tropism, and Retinal Gene Therapy Using Adeno-Associated Viral Vectors (AAVs) in New-Born Brown Norway Rats with a Spontaneous Mutation in
Boon N; Alves CH; Mulder AA; Andriessen CA; Buck TM; Quinn PMJ; Vos RM; Koster AJ; Jost CR; Wijnholds J
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808129
[TBL] [Abstract][Full Text] [Related]
16. A poly(ethylene) glycolylated peptide for ocular delivery compacts DNA into nanoparticles for gene delivery to post-mitotic tissues in vivo.
Read SP; Cashman SM; Kumar-Singh R
J Gene Med; 2010 Jan; 12(1):86-96. PubMed ID: 19937991
[TBL] [Abstract][Full Text] [Related]
17. In vivo transfer of a reporter gene to the retina mediated by an adenoviral vector.
Li T; Adamian M; Roof DJ; Berson EL; Dryja TP; Roessler BJ; Davidson BL
Invest Ophthalmol Vis Sci; 1994 Apr; 35(5):2543-9. PubMed ID: 8163343
[TBL] [Abstract][Full Text] [Related]
18. DNA nanoparticles are safe and nontoxic in non-human primate eyes.
Kelley RA; Conley SM; Makkia R; Watson JN; Han Z; Cooper MJ; Naash MI
Int J Nanomedicine; 2018; 13():1361-1379. PubMed ID: 29563793
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-restricted transgene expression in the retina.
Karali M; Manfredi A; Puppo A; Marrocco E; Gargiulo A; Allocca M; Corte MD; Rossi S; Giunti M; Bacci ML; Simonelli F; Surace EM; Banfi S; Auricchio A
PLoS One; 2011; 6(7):e22166. PubMed ID: 21818300
[TBL] [Abstract][Full Text] [Related]
20. DNA nanoparticle-mediated ABCA4 delivery rescues Stargardt dystrophy in mice.
Han Z; Conley SM; Makkia RS; Cooper MJ; Naash MI
J Clin Invest; 2012 Sep; 122(9):3221-6. PubMed ID: 22886305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
